未名医药
(002581)
| 流通市值：35.51亿 | | | 总市值：58.45亿 |
| 流通股本：4.01亿 | | | 总股本：6.60亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 35,329,856.7 | 360,405,014.1 | 314,710,263.52 | 210,782,004.46 |
| 营业收入 | 35,329,856.7 | 360,405,014.1 | 314,710,263.52 | 210,782,004.46 |
| 二、营业总成本 | 79,830,761.69 | 436,964,149.91 | 348,197,159.44 | 235,965,383.68 |
| 营业成本 | 7,089,265.29 | 72,856,966.86 | 62,188,032.99 | 40,782,935.75 |
| 税金及附加 | 1,442,249.15 | 6,374,426.65 | 4,885,829.59 | 3,271,040.29 |
| 销售费用 | 47,733,170.98 | 253,400,889.45 | 190,657,308.17 | 128,147,734.83 |
| 管理费用 | 19,488,936.28 | 83,247,558.12 | 74,211,796.58 | 52,561,938.92 |
| 研发费用 | 4,880,913.96 | 25,373,888.86 | 17,762,071.88 | 12,003,697.01 |
| 财务费用 | -803,773.97 | -4,289,580.03 | -1,507,879.77 | -801,963.12 |
| 其中:利息费用 | - | 197,305.59 | - | - |
| 其中:利息收入 | - | 4,545,187.9 | - | - |
| 加:投资收益 | -6,907,709.71 | 62,730,963.66 | 58,962,233.78 | 2,969,342.02 |
| 资产处置收益 | 627,572.81 | 1,158,184.8 | -3,306,128.17 | -4,141,640.1 |
| 资产减值损失(新) | -661,030.2 | -104,503,807.02 | 424,227.83 | 424,227.83 |
| 信用减值损失(新) | 947,770.53 | 5,089,082.88 | 3,587,705.31 | 1,085,087.62 |
| 其他收益 | 52,920.58 | 612,736.83 | 797,382.73 | 589,435.65 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -50,441,380.98 | -111,471,974.66 | 26,978,525.56 | -24,256,926.2 |
| 加:营业外收入 | 13,744.14 | 2,036,763.85 | 1,941,022.61 | 1,730,543.89 |
| 减:营业外支出 | 3,478.57 | 36,740,325.4 | 1,175,099.47 | 792,830.93 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -50,431,115.41 | -146,175,536.21 | 27,744,448.7 | -23,319,213.24 |
| 减:所得税费用 | -612,498.52 | -3,339,652.72 | 3,742,614.69 | 1,495,427.18 |
| 六、净利润 | -49,818,616.89 | -142,835,883.49 | 24,001,834.01 | -24,814,640.42 |
| 持续经营净利润 | -49,818,616.89 | -142,835,883.49 | 24,001,834.01 | -24,814,640.42 |
| 归属于母公司股东的净利润 | -36,850,397.17 | -137,313,572.01 | 14,626,268.3 | -29,614,917.07 |
| 少数股东损益 | -12,968,219.72 | -5,522,311.48 | 9,375,565.71 | 4,800,276.65 |
| (一)基本每股收益 | -0.06 | -0.21 | 0.02 | -0.04 |
| (二)稀释每股收益 | -0.06 | -0.21 | 0.02 | -0.04 |
| 九、综合收益总额 | -49,818,616.89 | -142,835,883.49 | 24,001,834.01 | -24,814,640.42 |
| 归属于母公司股东的综合收益总额 | -36,850,397.17 | -137,313,572.01 | 14,626,268.3 | -29,614,917.07 |
| 归属于少数股东的综合收益总额 | -12,968,219.72 | -5,522,311.48 | 9,375,565.71 | 4,800,276.65 |
| 公告日期 | 2025-04-29 | 2025-04-24 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 保留意见 | | |